Cannara Biotech Inc (LOVE.V)
0.81
+0.01
(+1.25%)
CAD |
TSXV |
May 17, 15:17
Cannara Biotech Total Assets (Quarterly): 145.82M for Feb. 29, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 145.82M |
November 30, 2023 | 144.82M |
August 31, 2023 | 141.52M |
May 31, 2023 | 135.37M |
February 28, 2023 | 129.15M |
November 30, 2022 | 125.43M |
August 31, 2022 | 125.62M |
May 31, 2022 | 106.83M |
February 28, 2022 | 101.69M |
November 30, 2021 | 102.14M |
August 31, 2021 | 92.02M |
Date | Value |
---|---|
May 31, 2021 | 57.93M |
February 28, 2021 | 54.20M |
November 30, 2020 | 51.56M |
August 31, 2020 | 54.85M |
May 31, 2020 | 57.87M |
February 29, 2020 | 59.22M |
November 30, 2019 | 61.88M |
August 31, 2019 | 68.10M |
May 31, 2019 | 67.79M |
February 28, 2019 | 69.95M |
November 30, 2018 | 0.0348M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
51.56M
Minimum
Nov 2020
145.82M
Maximum
Feb 2024
94.19M
Average
96.86M
Median
Total Assets (Quarterly) Benchmarks
Biocure Technology Inc | 1.976M |
Core One Labs Inc | 7.400M |
Nova Mentis Life Science Corp | 0.0539M |
Nanosphere Health Sciences Inc | 0.0238M |
Lobe Sciences Ltd | 2.109M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 66.48M |
Shareholders Equity (Quarterly) | 79.34M |
Debt to Equity Ratio | 0.6136 |
Current Ratio | 0.969 |
Net Debt Paydown Yield | -0.15% |